Tissue & cell · 2025
Fusobacterium nucleatum promotes bladder cancer progression and immune escape by activating the IL22/STAT3/PD-L1 signaling cascade.
СтатьяНазвание и аннотация: Перевод в очереди
Обработка статьи · этапы, ошибки и управление
Загрузка состояния…
Ошибки и ограничения
История · было → стало
Состояние обновляется каждые 5 секунд, пока блок открыт. Процент показывается только там, где известен объём работы. Пауза останавливает продолжение этапа; текущий запрос к источнику может завершиться.
Yang Yunjie, Chen Yang, Liu Qi, Guan Lixian, Liang Gengqi
Аннотация
OBJECTIVE: This study investigates the mechanism by which Fusobacterium nucleatum (Fn) promotes bladder cancer (BC) progression and immune escape through the interleukin 22 (IL22)/signal transducer and activator of transcription 3 (STAT3)/programmed death-ligand 1 (PD-L1) cascade signaling.
METHODS: Fecal samples from BC patients (n = 73) and healthy controls (n = 39) were analyzed for Fn abundance using qRT-PCR. IL-22, p-STAT3, STAT3, and PD-L1 levels were determined by qRT-PCR and western blot. The in vitro cultured human BC cell line (T24) were co-cultured with Fn, followed by CCK-8, colony formation, and Transwell assays to assess cell viability, proliferation, and invasion and migration, respectively. A co-culture system of T24 and CD8-positive T lymphocytes (CD8+ T) cells was established. Immune responses were assessed by determining tumor necrosis factor alpha (TNF-α), interferon gamma (INF-γ), granzyme B (GZMB), and pore-forming protein (Perforin) levels in supernatants. In vivo studies using a BC mouse model examined tumor progression and immune markers through flow cytometry, focusing on CD8+ T cells and regulatory T cell (Treg) populations. Immunohistochemical assay was conducted to measure ki67 levels in tumor tissues.
RESULTS: Fn levels were significantly elevated in BC patients' feces. Fn treatment enhanced cancer cell viability, proliferation, invasion, and migration. Fn activated the IL22/STAT3/PD-L1 pathway and showed positive correlations with these markers in BC tissues. In the co-culture system, Fn reduced CD8+ T cell function and increased Treg proportions in tumor tissues. The in vivo experiments confirmed that Fn promoted IL22/STAT3/PD-L1 expression, altered immune cell ratios, and increased ki67 expression levels.
CONCLUSION: Fn promotes the IL22/STAT3/PD-L1 cascade signaling, thereby facilitating in vivo progression and immune evasion of BC.
METHODS: Fecal samples from BC patients (n = 73) and healthy controls (n = 39) were analyzed for Fn abundance using qRT-PCR. IL-22, p-STAT3, STAT3, and PD-L1 levels were determined by qRT-PCR and western blot. The in vitro cultured human BC cell line (T24) were co-cultured with Fn, followed by CCK-8, colony formation, and Transwell assays to assess cell viability, proliferation, and invasion and migration, respectively. A co-culture system of T24 and CD8-positive T lymphocytes (CD8+ T) cells was established. Immune responses were assessed by determining tumor necrosis factor alpha (TNF-α), interferon gamma (INF-γ), granzyme B (GZMB), and pore-forming protein (Perforin) levels in supernatants. In vivo studies using a BC mouse model examined tumor progression and immune markers through flow cytometry, focusing on CD8+ T cells and regulatory T cell (Treg) populations. Immunohistochemical assay was conducted to measure ki67 levels in tumor tissues.
RESULTS: Fn levels were significantly elevated in BC patients' feces. Fn treatment enhanced cancer cell viability, proliferation, invasion, and migration. Fn activated the IL22/STAT3/PD-L1 pathway and showed positive correlations with these markers in BC tissues. In the co-culture system, Fn reduced CD8+ T cell function and increased Treg proportions in tumor tissues. The in vivo experiments confirmed that Fn promoted IL22/STAT3/PD-L1 expression, altered immune cell ratios, and increased ki67 expression levels.
CONCLUSION: Fn promotes the IL22/STAT3/PD-L1 cascade signaling, thereby facilitating in vivo progression and immune evasion of BC.